Alphabet Health Unit founder leaves company as company targets commercial uses

Verily Life Sciences, a healthcare unit of Alphabet said founder and CEO Andy Conrad would be replaced in the lead role, as the company tries to find commercial uses for its vast portfolio of projects.

Stephen Gillett, the current chairman of Verily, will succeed Mr Conrad as CEO in January next year, with Mr Conrad becoming executive chairman. Alphabet led a new $1 billion fundraising round at the company with other investors, Verily said Friday in a statement announcing the leadership changes.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button